Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > All news
Comittee for Medicinal Products for Human use : Minutes for the meeting on 23-26 January 2023
2023 April Apr 17

Comittee for Medicinal Products for Human use : Minutes for the meeting on 23-26 January 2023

Read more
EMA: Minutes of PRAC meeting on 28 Nov to 01 Dec 2022
2023 April Apr 14

EMA: Minutes of PRAC meeting on 28 Nov to 01 Dec 2022

Read more
How to limit the occurrence of adverse effects of mydriatic eye drops in children?
2023 April Apr 11

How to limit the occurrence of adverse effects of mydriatic eye drops in children?

https://ansm.sante.fr/actualites/comment-limiter-la-survenue-des-effets-indesirables-des-collyres-mydriatiques-chez-les-enfants?fbclid=IwAR0-r9IYprxvpZnb_cCXk249sawSqKCIWoxEv00kpqRWuMrMcqro7VGhg-s

Read more
2022 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission
2023 April Apr 07

2022 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission

Read more
About us – EMA
2023 April Apr 03

About us – EMA

Read more
Pharmacovigilance – Questions and answers – Access to medicines not authorised in France for the treatment of serious diseases – ANSM
2023 March Mar 30

Pharmacovigilance – Questions and answers – Access to medicines not authorised in France for the treatment of serious diseases – ANSM

Read more
2022 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission
2023 March Mar 27

2022 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission

Read more
WHO Pharmaceuticals Newsletter
2023 March Mar 23

WHO Pharmaceuticals Newsletter

Read more
Standing Scientific Committee on Surveillance and Pharmacovigilance – Restricted Expertise Session of 15 November 2022 minutes
2023 March Mar 20

Standing Scientific Committee on Surveillance and Pharmacovigilance – Restricted Expertise Session of 15 November 2022 minutes

Read more
Guideline on computerised systems and electronic data in clinical trials
2023 March Mar 17

Guideline on computerised systems and electronic data in clinical trials

Read more
  • « Previous
  • Next »

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • FAQ for the webinar on the new European legislation on clinical trials for medicinal products
  • EMA: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 – 12 May 2023
  • EMA – Annual Report 2022
Copyright © 2018 - Pharmya - Legal terms - Quality Policy